Literature DB >> 20709889

Lenalidomide-induced acute interstitial nephritis.

Evan J Lipson1, Carol Ann Huff, Danniele G Holanda, Michael A McDevitt, Derek M Fine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20709889      PMCID： PMC3228035          DOI： 10.1634/theoncologist.2010-0070

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  11 in total

1.  Drug-induced acute interstitial nephritis.

Authors:  J Rossert
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

2.  Renal failure with the use of zoledronic acid.

Authors:  Jennie T Chang; Lanh Green; Julie Beitz
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

3.  Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications.

Authors:  David H Chang; Nancy Liu; Virginia Klimek; Hani Hassoun; Amitabha Mazumder; Stephen D Nimer; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

Review 4.  Immunomodulatory drugs in myelodysplastic syndromes.

Authors:  Naomi Galili; Azra Raza
Journal:  Expert Opin Investig Drugs       Date:  2006-07       Impact factor: 6.206

5.  Azotemia associated with use of lenalidomide in plasma cell dyscrasias.

Authors:  Eric D Batts; Vaishali Sanchorawala; Yael Hegerfeldt; Hillard M Lazarus
Journal:  Leuk Lymphoma       Date:  2008-06

6.  Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

Authors:  Glen S Markowitz; Paul L Fine; Jay I Stack; Cheryl L Kunis; Jai Radhakrishnan; Winicjusz Palecki; Jin Park; Samih H Nasr; Shirley Hoh; David S Siegel; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-07       Impact factor: 10.612

7.  ["Occult" renal insufficiency due to evaluating renal function using only serum creatinine].

Authors:  G Fernández-Fresnedo; A L M de Francisco; E Rodrigo; C Piñera; I Herráez; J C Ruiz; M Arias
Journal:  Nefrologia       Date:  2002       Impact factor: 2.033

8.  Acute interstitial nephritis due to drugs: Review of the literature with a report of nine cases.

Authors:  A L Linton; W F Clark; A A Driedger; D I Turnbull; R M Lindsay
Journal:  Ann Intern Med       Date:  1980-11       Impact factor: 25.391

9.  The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.

Authors:  Christine Galustian; Brendan Meyer; Marie-Christine Labarthe; Keith Dredge; Deborah Klaschka; Jake Henry; Stephen Todryk; Roger Chen; George Muller; David Stirling; Peter Schafer; J Blake Bartlett; Angus G Dalgleish
Journal:  Cancer Immunol Immunother       Date:  2008-11-14       Impact factor: 6.968

Review 10.  Mechanism of action of lenalidomide in hematological malignancies.

Authors:  Venumadhav Kotla; Swati Goel; Sangeeta Nischal; Christoph Heuck; Kumar Vivek; Bhaskar Das; Amit Verma
Journal:  J Hematol Oncol       Date:  2009-08-12       Impact factor: 17.388
View more
  2 in total

Review 1.  Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.

Authors:  Rimda Wanchoo; Ala Abudayyeh; Mona Doshi; Amaka Edeani; Ilya G Glezerman; Divya Monga; Mitchell Rosner; Kenar D Jhaveri
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-21       Impact factor: 8.237

Review 2.  Anticancer Drug-Induced Acute Kidney Injury.

Authors:  Hassan Izzedine; Mark A Perazella
Journal:  Kidney Int Rep       Date:  2017-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.